| Dr William B Tyler Iii, MD | |
|
100 N Academy Ave, Danville, PA 17822-0131 | |
| (570) 271-6338 | |
| Not Available |
| Full Name | Dr William B Tyler Iii |
|---|---|
| Gender | Male |
| Speciality | Pathology - Dermatopathology |
| Location | 100 N Academy Ave, Danville, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972551588 | NPI | - | NPPES |
| 000957942 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD015078E (Pennsylvania) | Secondary |
| 207ZD0900X | Pathology - Dermatopathology | MD015078E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr William B Tyler Iii, MD 100 N Academy Ave, Danville, PA 17822-3034 Ph: (570) 271-6144 | Dr William B Tyler Iii, MD 100 N Academy Ave, Danville, PA 17822-0131 Ph: (570) 271-6338 |
News Archive
Scientists working at the MRC National Institute for Medical Research have shown that environmental factors can influence the development of autoimmune diseases like multiple sclerosis.
Upconversion emission materials are ideal for bioimaging due to its effectiveness as contrast agents for the detection of cancer cells, more so when the background emission of non-cancerous tissues can be minimised. These materials could be used as biomarkers for luminescent labeling of cancerous cells. Opaque tissues can be turned into glassy, transparent substances by using these biomarkers which rely on near-infrared excitation.
Climate change may progressively affect human health for the worse, requiring prompt and resolute action to stabilize it, reports a consortium of 27 leading scientific academies in Europe.
An Andalusian team of researchers led by the University of Granada has demonstrated the efficacy of a new drug against cancerogenic stem cells, which cause the onset and development of cancer, of relapse after chemotherapy and metastasis. This drug, called Bozepinib, has proved to be effective in tests with mice.
› Verified 3 days ago
Dr. Jeffrey W. Prichard, D.O. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6338 | |
Dr. Myra L. Wilkerson, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6338 Fax: 570-271-6105 | |
Dr. Steven C. Meschter, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6338 | |
Dr. Raj K. Rolston, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6338 | |
Dr. William Quinones, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6338 | |
Dr. Conrad Schuerch Iii, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6338 | |
Dr. Kai Zhang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 100 N Academy Ave, Danville, PA 17822 Phone: 570-271-6338 |